Home > Journals > Medicine > Sang Thrombose Vaisseaux > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Sang Thrombose Vaisseaux
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Peripheral lipodystrophy and metabolic disorders in HIV infection


Sang Thrombose Vaisseaux. Volume 11, Number 10, 753-60, Décembre 1999, Mini-revues

Résumé   Article gratuit  

Author(s) : Sophie Morelon, Caroline Dupont, Marie-Laure Raffin-Sanson

Summary : Over the last two years, abnormal body fat distribution and changes in lipid and carbohydrate metabolism have been observed in HIV 1 infected patients, sometimes associated with severe and early coronary artery disease. These abnormalities essentially occur in patients receiving highly active antiretroviral therapies. The so-called “lipodystrophy” includes various degrees of central visceral fat accumulation, fat deposition in the breasts and the dorsocervical spine, and peripheral fat wasting (limbs and face). In some patients, wasting is the predominant feature; in others, increased adiposity of the trunk prevails. Hypertriglyceridemia or combined hyperlipidemia and insulin resistance may be associated with fat redistribution or may occur in isolation. Diabetes is unfrequent. The prevalence of this syndrome varies widely, according to the studies, from 12 to 83%. The cause(s) of the syndrome(s) is unknown. Antiretrovial therapies are most probably involved, but also HIV infection itself or modifications of immunity play a role. Factors independently correlated with the risk of fat redistribution are a longer duration of antiretroviral therapy, the use of protease-inhibitors and/or 3TC and a high initial viral load. The consequences of these syndromes are psychological (aesthetic alteration of body shape) and pancreatic (in cases of severe hypertriglyceridemia). Moreover, early acute vascular events (mostly related to coronary artery disease) have also been reported in patients given antiretroviral drugs. Therapy for metabolic abnormalities is mostly grounded on dietary counselling; the safety and efficacy of lipid and glucose lowering drugs has to be assessed. At present, no specific treatment is available for the correction of fat redistribution.

Keywords :

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]